Water Cooler Chat: Best Practice on Setting Health-Based Cleaning Limits in a Multi-product Facility

PCI Pharma

David O’Connell
PCI, Director of Scientific Affairs

Gareth Phillips
PCI, Senior Development Scientist

Dean Calhoun
Affygility Solutions
International potent compound safety expert, Founder and CEO

When different medicinal products are produced in shared facilities, the potential for cross-contamination is a concern. Medicinal products provide a benefit to the intended patient; however, as a cross contaminant, they provide no benefit and may even pose a risk. Hence, the presence of such contaminants should be managed according to the risk posed which in turn are related to levels that can be considered safe for all populations. Learn more about setting Allowable Daily Exposure (ADE)/Permitted Daily Exposure (PDE) limits.

Listen to Full Water Cooler Chat